POINT Biopharma Global Inc.
PNTDelisted Dec 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001811764
POINT Biopharma Global Inc. was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Dec 27, 2023; 126 institutions reported holding it in 13F filings for Q3 2023, worth $411.0M in total; no superinvestor held it.
Holders of 5% or more of PNT
Holders whose latest Schedule 13D or 13G filing reports 5% or more of POINT Biopharma Global Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of POINT Biopharma Global Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on POINT Biopharma Global Inc., newest first.
No Schedule 13D or 13G filings on POINT Biopharma Global Inc. are on file.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell POINT Biopharma Global Inc. shares.
No Form 144 notices for POINT Biopharma Global Inc. are on file.